Chapel Hill, NC (May 12, 2021)- Devana Solutions, LLC is pleased to announce their newest client-partnership with MOORE Clinical Research, a privately owned and operated multi-specialty research site specializing in Phase II-IV clinical trials. Founded in 2006, MOORE has completed over 500 clinical trials across their vast and diverse patient population at their three locations in the Tampa Bay area of Florida. Through years of experience and success, MOORE continues to innovate and improve their processes to adapt to the ever-changing clinical trials landscape.

MOORE’s forward-thinking leadership began looking into new technologies to help improve efficiencies around trial identification and management. Already armed with the RealTime CTMS platform, MOORE was introduced to Devana Solutions since the two tech companies have a seamless API-integration. Now, with the two platforms in place, MOORE is able to track trial opportunities from pre-award through trial completion, resulting in an abundance of reportable performance metrics to share with Sponsors and CROs.

“Moore Clinical Research is an excellent addition to our Devana Solutions’ client-partner, hyperCORE International. Moore and the entire hyperCORE super network, which is now over 100 sites worldwide, are able to leverage our Devana IGNITE & PROPEL platforms to rapidly mobilize in study startup and to mine robust analytics and reporting to ensure the organization remains one of the most predictable and reliable performers in the clinical trials industry,” said Barry Lake, CEO, and Co-Founder of Devana Solutions, LLC.

By leveraging Devana’s pioneering platforms, MOORE hopes to continue to increase their trial volume by expanding their capabilities into more therapeutic areas. After implementing Devana’s IGNITE platform, MOORE has already doubled their total number of feasibility requests and site qualification visits per month. With this increase, MOORE is well on their way to exceeding the goals set in place for 2021. Devana Solutions is looking forward to being a part of MOORE’s continued growth and success!

ABOUT MOORE CLINICAL RESEARCH

Founded in 2006, MOORE Clinical Research, Inc. is a privately owned and operated clinical trial site specializing and experienced in conducting multi-specialty Phase II-IV clinical trials. We have three site locations across the Tampa Bay area, each covering a large and diverse patient base.

Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity, and reliability. Since our inception in 2006, our demonstrated track record puts MOORE Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.

To learn more, please visit https://mooreclinicalresearch.com.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for sharing performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.

CHAPEL HILL, NC (April 14, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with the Icon Group, Australia’s largest dedicated provider of private cancer care. Icon Group has an extensive clinical trials program, and through its continuing growth, Devana’s IGNITE platform will help support their ongoing success.

Icon Research provides patients and clinicians with access to new and emerging advances in cancer treatment, conducting trials in hematology, medical oncology, and radiation oncology across a wide range of cancer types. Within the private setting, Icon Research has an unparalleled track record of participating in national and international clinical trials, including Phase I to IV, pharmaceutical industry-sponsored, and collaborative studies undertaken in partnership with various universities and collaborative groups.

Alongside the extensive clinical trials program, Icon Research conducts in-house clinical studies across clinical hematology, medical oncology, radiation oncology, nursing, pharmacy, and medical physics. This research provides professional development opportunities to Icon investigators and the wider Icon team and continues to pave the way for new advances in quality cancer care.

In 2020, Icon Research initiated an internal restructure to better support their expected growth, which led them to Devana Solutions. Devana’s IGNITE platform will help increase the ease and efficiency in research feasibility and start-up processes. This platform allows pre-CTMS data collection to occur, standardized reporting, pipeline tracking, and automated workflows, all of which reduce the time it takes for a trial to begin. IGNITE integrates with Icon’s preferred CTMS, RealTime, allowing a seamless transfer of a trial from feasibility and start-up assessment into an active and financially tracked clinical trial. This integration removes the need for duplicate data entry and prevents the loss of important assessment data previously collected.

Devana Solutions supports some of the leading cancer research organizations worldwide, and the Icon Group is no exception. Their tireless dedication to combatting such an invasive and devastating disease is evident in all they do. Devana is honored to help support their efforts in advancing cancer therapies through their innovative and intuitive platforms.

ABOUT ICON GROUP:

Icon Group is Australia’s largest dedicated private provider of cancer care with a growing reach into Asia and New Zealand. The Group is built on a strong but simple vision to deliver the best care possible to as many people as possible, as close to home as possible.

Icon Group’s integrated, end-to-end service model leverages the strengths of a diverse, multi-disciplinary team to achieve this mission. Their businesses encompass all aspects of quality cancer care, including treatment delivery, pharmacy, and chemotherapy compounding. To learn more, visit https://icongroup.global.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.

CHAPEL HILL, NC (February 19, 2021) — Devana Solutions, LLC is proud to announce their newest client-partnership with Indiana Clinical Trials Center (ICTC). The collaboration of Devana’s IGNITE platform and the highly experienced independent research site will allow ICTC to effectively expand their investigative footprint across a growing number of Dermatology practices.

The Indiana Clinical Trials Center was founded in 2005 by Dr. Scott Guenthner, who has conducted over 180 Phase I-IV Dermatology studies. The organization is continuing to grow and their parent company, Summit Dermatology, plans to open more sites in the Midwest over the next few years. The Indiana Clinical Trials Center’s Plainfield location will remain the central core for all new clinical trials.

During this exciting growth period, ICTC’s use of the Devana IGNITE platform will be a vehicle to efficiently manage their trial pipeline and startup for their current and future site locations. ICTC’s central coordinating team will have real-time transparency into each site’s trial activities and performance metrics, with the ability to share accurate data with Sponsors and CROs, helping to boost their predictability and reliability. “In order to stay on target with their growth strategy, ICTC needs to grow Sponsor and CRO confidence in their ability to not only meet enrollment goals, but to rapidly get a trial up and running,” said Emily Wike, Devana’s Director of Strategic Partnerships. “Devana’s robust metrics capture and reporting will be the source of truth for ICTC and will be extremely valuable to their Sponsor and CRO partners.”

ICTC, equipped with forward-thinking leadership, a highly experienced clinical team and now, Devana’s IGNITE platform, will help to catapult them to the next level. There is no doubt that ICTC is on the path to much success and Devana Solutions is delighted to be along their side for this journey.

ABOUT INDIANA CLINICAL TRIALS CENTER:

The Indiana Clinical Trials Center (ICTC) is a comprehensive and highly experienced clinical research site focusing primarily on Phase I – IV dermatologic clinical trials. ICTC is a successful extension of The Dermatology Center of Indiana (DCI) located in Plainfield, Indiana. To learn more visit https://dermindy.com/ictc-2.

ABOUT DEVANA SOLUTIONS LLC:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

CHAPEL HILL, NC (February 18, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with Optimed Research, a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials. Optimed Research’s main site in Columbus, Ohio, is the central hub where they run over thirty trials under the direction of Owner and Founder Dr. Donald McNeil.

Through the Integrated Research Organization model, Optimed Research partners with independent sites in their network. With a comprehensive Clinical Research Coordinator (CRC) training program, Optimed can take a CRC with little to no experience to running a trial independently. Optimed oversees business development, regulatory, data management, and financial support for each of the independent sites, allowing the Investigator and clinical staff to focus on the trial participants and meeting enrollment goals. This process helps to spread clinical trial awareness on a much broader scope.

Due to the vast amount of oversight that Optimed provides to their sites, their VP & Director of Clinical Operations, Annie Schertzer, set out to find a solution to help manage their workload. Annie and other Optimed staff knew it was time to ditch the static spreadsheets to continue with their trending growth. With the addition of the Devana Solutions IGNITE platform, Optimed Research has a more efficient way to manage all of their independent sites within one cloud-based platform, from initial trial lead through trial completion, since Devana integrates with their CTMS, Clinical Research IO. “Optimed Research was already on the cutting-edge of clinical research with their IRO model and CRC training program, but now armed with the IGNITE platform, there are no limitations to what this group can do,” said Devana’s Director of Strategic Partnerships, Emily Wike. “I am excited to see what the future holds for Optimed!”

Devana Solutions is pleased to stand alongside Optimed Research as they continue to grow their network of sites, proving that clinical research can be accessible to all!

About Optimed Research

Optimed Research is proud to be a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials.  Optimed – Columbus houses our team of experts who support all of the sites in our network.  Please visit www.optimedresearch.com for more information.

About Devana Solutions

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.